Now showing items 1-5 of 5

    • Solís, Yanahara; Álvarez, Ana M.; Fuentes, David; Barra, Daniela de la; Avilés, Carmen L.; Becker, Ana; Salgado, Carmen; Silva, Pamela; Topelberg, Santiago; Tordecilla, Juan; Varas, Mónica; Villarroel, Milena; Viviani, Tamara; Zubieta, Marcela; Aedo Monsalve, Sócrates; Santolaya de Pablo, María Elena (2012)
      Introduction: To determine the etiology of invasive bacterial infection in high risk febrile neutropenia (HRFN) episodes in children with cancer is essential because of the favorable impact on mortality of the early empiric ...
    • Santolaya de Pablo, María Elena; Alvarez, Ana M.; Avilés, Carmen L.; Becker, Ana; Cofré, José; Cumsille Garib, Miguel; O'Ryan Gallardo, Miguel; Payá, Ernesto; Salgado, Carmen; Silva, Pamela; Tordecilla, Juan; Varas P., Mónica; Villarroel, Milena; Viviani, Tamara; Zubieta, Marcela (2004-09-15)
      Purpose To compare outcome and cost of ambulatory versus hospitalized management among febrile neutropenic children at low risk for invasive bacterial infection (IBI). Patients and Methods Children presenting with ...
    • Muñoz M., Marcela; Rodríguez Z., Natalie; Tordecilla, Juan; Ureta H., Ester; Rizzardini L., Carlos; Soto A., Verónica; Wensioe Rogat, Karin (Sociedad Chilena de Pediatría, 2009-08)
      “Peliosis Hepatis” as a Complication of the Ise of Oral Contraceptives in a Patient with Myelodysplasia Introduction: Peliosis hepatis (PH) is an uncommon condition in pediatrics; however, it is one of the most serious ...
    • Santolaya de Pablo, María Elena; Alvarez, Ana M.; Avilés, Carmen L.; Becker, Ana; Venegas, Marcela; O'Ryan Gallardo, Miguel; Salgado, Carmen; Topelberg, Santiago; Tordecilla, Juan; Varas, Mónica; Villarroel, Milena; Viviani, Tamara; Zubieta, Marcela; Maza León, Verónica de la; Vergara, Alejandra; Farfán, Mauricio J.; Torres Torretti, Juan Pablo (Lippincott Williams & Wilkins, 2013)
      Background: We previously created a risk prediction model for severe sepsis not clinically apparent during the first 24 hours of hospitalization in children with high-risk febrile neutropenia (HRFN), which identified 3 ...
    • Santolaya de Pablo, María Elena; Alvarez, Ana M.; Becker, Ana; Cofré, José; Enríquez, N.; O'Ryan Gallardo, Miguel; Payá, Ernesto; Pilorget, J.; Salgado, Carmen; Tordecilla, Juan; Varas P., Mónica; Villarroel, Milena; Viviani, Tamara; Zubieta, Marcela (2001-07-15)
      Purpose: To identify clinical and laboratory parameters present at the time of a first evaluation that could help predict which children with cancer, fever, and neutropenia were at high risk or low risk for an ...